Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies ForGrowth NAP B.V. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael H. Davidson - $25.33M of NAMS open-market activity in the last 12 months
- Louise Frederika Kooij - $21.08M of NAMS open-market activity in the last 12 months
- Johannes Jacob Pieter Kastelein - $14.26M of NAMS open-market activity in the last 12 months
- Mayur Ian Somaiya - $3.43M of NAMS open-market activity in the last 12 months
- Louis G. Lange - $2.19M of NAMS open-market activity in the last 12 months
- James N. Topper - $47K of NAMS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is ForGrowth NAP B.V.?
ForGrowth NAP B.V. is a corporate entity of NewAmsterdam Pharma Co N.V. (NAMS). InsiderAlpha holds 8 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did ForGrowth NAP B.V. last file a Form 4?
The most recent primary Form 4 on record is dated 30 December 2024, one of 8 filings going back to 2024.
Has ForGrowth NAP B.V. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 24 open-market sales ($29.26M) across all tracked filings.
Where can I see all of ForGrowth NAP B.V.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow ForGrowth NAP B.V. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
